Total Payments
$85,496
2024 Payments
$264.38
Companies
13
Transactions
54
Medicare Patients
14,564
Medicare Billing
$12.5M
Payment Breakdown by Category
Consulting$56,440 (66.0%)
Other$28,350 (33.2%)
Food & Beverage$686.21 (0.8%)
Gifts$19.40 (0.0%)
Education$0.83 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $56,440 | 27 | 66.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $28,350 | 2 | 33.2% |
| Food and Beverage | $686.21 | 23 | 0.8% |
| Gift | $19.40 | 1 | 0.0% |
| Education | $0.83 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Baxter Healthcare | $45,805 | 24 | $0 (2023) |
| Welch Allyn | $38,997 | 6 | $0 (2019) |
| Alimera Sciences, Inc. | $264.38 | 3 | $0 (2024) |
| Genentech USA, Inc. | $121.84 | 4 | $0 (2022) |
| ABBVIE INC. | $73.79 | 5 | $0 (2022) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $64.89 | 1 | $0 (2018) |
| Allergan, Inc. | $58.59 | 4 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $33.35 | 2 | $0 (2022) |
| Genentech, Inc. | $23.36 | 1 | $0 (2023) |
| Carl Zeiss Meditec AG | $19.40 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $264.38 | 3 | Alimera Sciences, Inc. ($264.38) |
| 2023 | $26,453 | 13 | Baxter Healthcare ($26,430) |
| 2022 | $19,523 | 21 | Baxter Healthcare ($19,375) |
| 2021 | $28.55 | 2 | Allergan, Inc. ($28.55) |
| 2020 | $76.09 | 5 | Allergan, Inc. ($30.04) |
| 2019 | $5,212 | 4 | Welch Allyn ($5,135) |
| 2018 | $5,915 | 2 | Welch Allyn ($5,850) |
| 2017 | $28,025 | 4 | Welch Allyn ($28,012) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 06/25/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $121.17 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 02/15/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $132.31 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 12/08/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $2,890.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 11/15/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $2,460.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 10/13/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $2,205.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 09/08/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $2,390.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 08/11/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $2,145.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 07/24/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $2,175.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 06/16/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $2,375.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 05/12/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $2,285.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 04/21/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $2,095.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 03/10/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $2,090.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 02/23/2023 | Genentech, Inc. | Susvimo (Drug), Vabysmo | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/06/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $1,730.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 01/20/2023 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $1,590.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 12/16/2022 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $1,795.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 11/15/2022 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $1,835.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 10/27/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: RETINA | ||||||
| 10/06/2022 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 09/08/2022 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $1,550.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 09/01/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: RETINA | ||||||
| 08/05/2022 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $1,660.00 | General |
| Category: Physical Assessment, Vision | ||||||
| 08/04/2022 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $21.17 | General |
| 07/06/2022 | Baxter Healthcare | Hillrom - RetinaVue 700 Imager (Device), Hillrom - RetinaVue Network | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| Category: Physical Assessment, Vision | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,950 | 29,220 | $4.6M | $2.8M |
| 2022 | 19 | 3,388 | 16,315 | $5.6M | $3.4M |
| 2021 | 18 | 4,012 | 14,129 | $5.2M | $3.3M |
| 2020 | 21 | 4,214 | 14,319 | $4.6M | $3.0M |
Total Patients
14,564
Total Services
73,983
Medicare Billing
$12.5M
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 278 | 2,622 | $2.9M | $1.8M | 61.3% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 74 | 20,220 | $821,536 | $540,731 | 65.8% |
| 67028 | Injection of drug into eye | Office | 2023 | 388 | 1,496 | $223,072 | $138,616 | 62.1% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 34 | 769 | $346,840 | $136,445 | 39.3% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 667 | 908 | $118,884 | $80,249 | 67.5% |
| 92134 | Imaging of retina | Office | 2023 | 805 | 2,248 | $94,955 | $64,177 | 67.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 246 | 326 | $30,320 | $19,098 | 63.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 109 | 122 | $15,562 | $10,760 | 69.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 88 | 88 | $15,088 | $9,999 | 66.3% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 32 | 107 | $13,375 | $7,099 | 53.1% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 63 | 89 | $5,332 | $4,163 | 78.1% |
| 99427 | Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 57 | 79 | $3,663 | $2,872 | 78.4% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 14 | 14 | $3,332 | $2,518 | 75.6% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 21 | 21 | $2,881 | $2,178 | 75.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $2,824 | $1,858 | 65.8% |
| 92250 | Photography of the retina | Office | 2023 | 43 | 66 | $3,121 | $1,731 | 55.5% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 19 | 33 | $1,589 | $1,166 | 73.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 310 | 3,262 | $3.7M | $2.3M | 63.6% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 70 | 1,735 | $798,100 | $385,302 | 48.3% |
| 67028 | Injection of drug into eye | Office | 2022 | 448 | 1,965 | $284,991 | $180,448 | 63.3% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 34 | 4,200 | $173,881 | $123,544 | 71.1% |
| J3590 | Unclassified biologics | Office | 2022 | 25 | 54 | $132,500 | $91,148 | 68.8% |
| J0179 | Injection, brolucizumab-dbll, 1 mg | Office | 2022 | 20 | 324 | $124,740 | $80,334 | 64.4% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 699 | 904 | $119,344 | $76,497 | 64.1% |
| 92134 | Imaging of retina | Office | 2022 | 899 | 2,460 | $103,270 | $71,696 | 69.4% |
About Dr. Max Johnson, MD
Dr. Max Johnson, MD is a Retina Specialist healthcare provider based in Fargo, North Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1679559975.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Max Johnson, MD has received a total of $85,496 in payments from pharmaceutical and medical device companies, with $264.38 received in 2024. These payments were reported across 54 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($56,440).
As a Medicare-enrolled provider, Johnson has provided services to 14,564 Medicare beneficiaries, totaling 73,983 services with total Medicare billing of $12.5M. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Location Fargo, ND
- Active Since 12/19/2005
- Last Updated 01/04/2022
- Taxonomy Code 207WX0107X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679559975
Products in Payments
- Hillrom - RetinaVue 700 Imager (Device) $45,805
- RetinaVue 100 Imager (Device) $33,862
- RetinaVue Network (Device) $5,135
- YUTIQ (Drug) $264.38
- OZURDEX (Drug) $132.38
- Lucentis (Biological) $100.67
- STELLARIS PC (Device) $64.89
- XIPERE (Drug) $33.35
- Susvimo (Drug) $23.36
- None Specified (Medical Supply) $19.40
- EVA, combined machine (Device) $19.20
- DEXYCU (Drug) $14.45
- (820) Cholbam (Drug) $0.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.